Advances in Antiviral Drug Design -

Advances in Antiviral Drug Design

E. De Clercq (Herausgeber)

Buch | Hardcover
264 Seiten
2007
Elsevier Science Ltd (Verlag)
978-0-444-52173-6 (ISBN)
129,95 inkl. MwSt
Reviews the conceptual design and chemical synthesis of new antiviral compounds. This volume discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.
Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.

Status presens of antiviral drugs and strategies, Part I: DNA viruses and retroviruses
Status presens of antiviral drugs and strategies, Part II: RNA viruses (except retroviruses)
Methylenecyclopropane analogues of nucleosides as anti-herpes agents
Synthesis and antiviral evaluation of broad spectrum orally active analogs of cidofovir and other acyclic nucleoside phosphonates
CCR5 antagonists for the treatment of HIV infection and AIDS
The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Reihe/Serie Advances in Antiviral Drug Design
Verlagsort Oxford
Sprache englisch
Maße 152 x 229 mm
Gewicht 550 g
Themenwelt Naturwissenschaften Biologie Mikrobiologie / Immunologie
ISBN-10 0-444-52173-9 / 0444521739
ISBN-13 978-0-444-52173-6 / 9780444521736
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Allgemeine Grundlagen und spezielle Anwendungen

von Gerhard Gstraunthaler; Toni Lindl

Buch | Softcover (2021)
Springer Berlin (Verlag)
54,99